Notably, while MiCU1 displayed heightened expression in luminal and Her2+ subtypes, no significant difference was noted in triple-negative breast cancer (TNBC), contrasting with MiCU2. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.